European Journal of Pharmacology 1991-07-09

(S)-UH-301 antagonizes (R)-8-OH-DPAT-induced cardiovascular effects in the rat.

L Björk, S Lindgren, U Hacksell, T Lewander

Index: Eur. J. Pharmacol. 199 , 367, (1991)

Full Text: HTML

Abstract

The 5-HT1A-receptor antagonist (S)-UH-301 (S)-5-fluoro-8-hydroxy-2- (dipropylamino)tetralin) completely antagonized the hypotension and bradycardia induced by (R) = 8-OH DPAT [R)-8-hydroxy-2- (dipropylamino)tetralin) in conscious rats. (S)-UH-301 alone induced a weak hypertension, which might be due to its 5-HT1A-receptor antagonistic properties. (R)-UH-301 induced effects similar to those of (R)-8-OH DPAT, i.e., a short initial phase of hypertension followed by a long-lasting hypotension and bradycardia. Thus, (R)-UH-301 behaves as a 5-HT1A-receptor agonist and (S)-UH-301 as a 5-HT1A-receptor antagonist, abolishing the effects induced by (R)-8-OH DPAT.


Related Compounds

Related Articles:

In vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptors.

1999-01-01

[Eur. Neuropsychopharmacol. 9 , 15-19, (1999)]

Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.

1991-07-01

[J. Pharmacol. Exp. Ther. 258 , 58, (1991)]

The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons.

1993-04-01

[Naunyn Schmiedebergs Arch. Pharmacol. 347 , 353-362, (1993)]

Synthesis and pharmacology of the enantiomers of UH301: opposing interactions with 5-HT1A receptors.

1996-01-01

[Chirality 8 , 531-544, (1996)]

More Articles...